Why the study?
Does intracoronary urokinase resolve intracoronary thrombi and prevent myocardial infarction in patients with Kawasaki disease and giant coronary aneurysms?
Population
15 patients with Kawasaki disease with giant coronary aneurysms
Design
Case_series
Follow-up
mean 3.3 years (range >2 to 8 years)
Authors
Loading...
May support intracoronary urokinase for thrombus resolution in Kawasaki giant aneurysms; hypothesis-generating and should not yet change practice.
Does intracoronary urokinase resolve intracoronary thrombi and prevent myocardial infarction in patients with Kawasaki disease and giant coronary aneurysms?
Intracoronary urokinase may be an effective strategy for resolving intracoronary thrombi and preventing myocardial infarction in patients with Kawasaki disease complicated by giant coronary aneurysms.
Kato et al. (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: